checkAd
    Startseite > Aktien > Genmab > Nachrichten
    Genmab
    Aktie
    ISIN: DK0010272202 WKN: 565131 SYM: GE9 Land Dänemark
    Zur Watchlist hinzufügen Zum Portfolio hinzufügen
    241,70
     
    EUR
    -1,31 %
    -3,20 EUR
    Letzter Kurs 17:43:06 Tradegate
    Geldkurs
    19:18:58
    240,10
     
    EUR
    25 STK
    Briefkurs
    19:18:58
    242,00
     
    EUR
    25 STK

    Genmab Aktie kaufen

    Kauf
    Verkauf

    Neueste Nachrichten

    Transactions in Connection with Share Buy-back Program
    15:33 Uhr · globenewswire · Genmab
    Grant of Restricted Stock Units and Warrants to Employees in Genmab
    12.06.24 · globenewswire · Genmab
    Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
    11.06.24 · globenewswire · Genmab
    Transactions in Connection with Share Buy-back Program
    10.06.24 · globenewswire · Genmab
    Genmab to Participate in a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference
    05.06.24 · globenewswire · Genmab
    Transactions in Connection with Share Buy-back Program
    03.06.24 · globenewswire · Genmab
    Investigational Tisotumab Vedotin Phase 2 Data Demonstrates Encouraging Antitumor Activity in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
    03.06.24 · globenewswire · Genmab
    Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma
    02.06.24 · globenewswire · Genmab
    Investigational Acasunlimab (DuoBody -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
    01.06.24 · globenewswire · Genmab
    Transactions in Connection with Share Buy-back Program
    27.05.24 · globenewswire · Genmab
    Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
    23.05.24 · globenewswire · Genmab
    Genmab Completes Acquisition of ProfoundBio
    21.05.24 · globenewswire · Genmab